Search research articles
Contact Us
Filters
Showing results (291-300 of 376) with videos related to
Page
of 38
Sort By:
Atencion Primaria
|
May 26, 1999
[Prevalence of psychiatric disorders in primary care using the PRIME-MD questionnaire]
E Baca Baldomero, J Sáiz Ruiz, L F Agüera Ortiz, et al.
Journal of the American Academy of Dermatology
|
March 12, 2023
Pain of local anesthetic injection of lidocaine during subsequent stages of Mohs micrographic surgery: A multicenter prospective cohort study
McKenzie A Dirr, Rachel E Christensen, Noor Anvery, et al.
Journal of the American Academy of Dermatology
|
October 1, 2013
Levamisole toxicity mimicking autoimmune disease
Lauren Strazzula, Katherine K Brown, Joaquin C Brieva, et al.
Plos One
|
July 20, 2007
Primate TNF promoters reveal markers of phylogeny and evolution of innate immunity
Andres Baena, Alan R Mootnick, James V Falvo, et al.
Journal of Neurology
|
March 18, 2023
A prospective study of cellular immune response to booster COVID-19 vaccination in multiple sclerosis patients treated with a broad spectrum of disease-modifying therapies
Pascual Torres, Agustín Sancho-Saldaña, Anna Gil Sánchez, et al.
Tissue Antigens
|
September 28, 2005
The functional genetic variation in the PTPN22 gene has a negligible effect on the susceptibility to develop inflammatory bowel disease
M C Martín, J Oliver, E Urcelay, et al.
European Journal of Neurology
|
October 24, 2018
Comparison of two high doses of oral methylprednisolone for multiple sclerosis relapses: a pilot, multicentre, randomized, double-blind, non-inferiority trial
J V Hervás-García, L Ramió-Torrentà, L Brieva-Ruiz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
May 8, 2025
Cognitive test performance and disease progression in primary and secondary progressive MS: An analysis of the SPRINT-MS study
Victoria M Leavitt, Robert Fox, Jop Mostert, et al.
Journal of Medical Economics
|
June 24, 2026
From options to decisions: an innovative model for treatment sequencing in relapsing-remitting multiple sclerosis
Celia Oreja-Guevara, Lamberto Landete, Miguel Ángel Rodriguez Sagrado, et al.
Archives of Neurology
|
November 16, 2011
Interferon β-1b for the treatment of primary progressive multiple sclerosis: five-year clinical trial follow-up
Carmen Tur, Xavier Montalban, Mar Tintoré, et al.
Page
of 38
Search research articles
Search
Showing results (291-300 of 376) with videos related to
Sort By:
Page
of 38
Atencion Primaria
|
May 26, 1999
[Prevalence of psychiatric disorders in primary care using the PRIME-MD questionnaire]
E Baca Baldomero, J Sáiz Ruiz, L F Agüera Ortiz, et al.
Journal of the American Academy of Dermatology
|
March 12, 2023
Pain of local anesthetic injection of lidocaine during subsequent stages of Mohs micrographic surgery: A multicenter prospective cohort study
McKenzie A Dirr, Rachel E Christensen, Noor Anvery, et al.
Journal of the American Academy of Dermatology
|
October 1, 2013
Levamisole toxicity mimicking autoimmune disease
Lauren Strazzula, Katherine K Brown, Joaquin C Brieva, et al.
Plos One
|
July 20, 2007
Primate TNF promoters reveal markers of phylogeny and evolution of innate immunity
Andres Baena, Alan R Mootnick, James V Falvo, et al.
Journal of Neurology
|
March 18, 2023
A prospective study of cellular immune response to booster COVID-19 vaccination in multiple sclerosis patients treated with a broad spectrum of disease-modifying therapies
Pascual Torres, Agustín Sancho-Saldaña, Anna Gil Sánchez, et al.
Tissue Antigens
|
September 28, 2005
The functional genetic variation in the PTPN22 gene has a negligible effect on the susceptibility to develop inflammatory bowel disease
M C Martín, J Oliver, E Urcelay, et al.
European Journal of Neurology
|
October 24, 2018
Comparison of two high doses of oral methylprednisolone for multiple sclerosis relapses: a pilot, multicentre, randomized, double-blind, non-inferiority trial
J V Hervás-García, L Ramió-Torrentà, L Brieva-Ruiz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
May 8, 2025
Cognitive test performance and disease progression in primary and secondary progressive MS: An analysis of the SPRINT-MS study
Victoria M Leavitt, Robert Fox, Jop Mostert, et al.
Journal of Medical Economics
|
June 24, 2026
From options to decisions: an innovative model for treatment sequencing in relapsing-remitting multiple sclerosis
Celia Oreja-Guevara, Lamberto Landete, Miguel Ángel Rodriguez Sagrado, et al.
Archives of Neurology
|
November 16, 2011
Interferon β-1b for the treatment of primary progressive multiple sclerosis: five-year clinical trial follow-up
Carmen Tur, Xavier Montalban, Mar Tintoré, et al.
Page
of 38